T-mobile Us Insider Sold Shares Worth $489,660, According to a Recent SEC Filing-March 2024-www.financetom.com

T-mobile Us Insider Sold Shares Worth $489,660, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

T-mobile Us Insider Sold Shares Worth $489,660, According to a Recent SEC Filing

Apr 2, 2024 2:23 PM

05:07 PM EDT, 04/02/2024 (MT Newswires) -- Michael J. Katz, President, Marketing, Strategy, and Products, on April 01, 2024, sold 3,000 shares in T-mobile Us ( TMUS ) for $489,660. Following the Form 4 filing with the SEC, Katz has control over a total of 125,687 shares of the company, with 125,687 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1283699/000128369924000057/xslF345X03/wk-form4_1712091767.xml

Price: 162.16, Change: +0.08, Percent Change: +0.05

Previous page： Sector Update: Consumer Next page： Hospital Chain Operator HCA Healthcare Says Positive Q2 Earnings Reflect Strong Demand For Services, Issues Upbeat Annual Outlook

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Sector Update: Consumer

Jul 23, 2024

01:24 PM EDT, 07/23/2024 (MT Newswires) -- Consumer stocks were softer Tuesday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) shedding 0.2% and the Consumer Discretionary Select Sector SPDR Fund (XLY) fractionally lower. Redbook US same-store sales rose by 4 .9% from a year earlier in the week ended July 20 after a 4.8% year-over-year increase in the...

Hospital Chain Operator HCA Healthcare Says Positive Q2 Earnings Reflect Strong Demand For Services, Issues Upbeat Annual Outlook

Jul 23, 2024

On Tuesday, HCA Healthcare Inc. ( HCA ) reported second-quarter revenues of $17.49 billion, up from $15.86 billion a year ago and beating the consensus of $17.05 billion. The hospital chain reported adjusted EPS of $5.50, up from $4.29 a year ago, beating the consensus of $5.36. “The company’s results for the second quarter were positive and reflected strong demand for...

Cellectar Shares Fall as Updated Data For Investigational Radiotherapy Shows Drop in Major Response Rate

Jul 23, 2024

01:26 PM EDT, 07/23/2024 (MT Newswires) -- Cellectar Biosciences ( CLRB ) shares were down nearly 19% in recent Tuesday trading after the company released updated data for its investigational radiotherapy Iopofosine I 131, showing a drop in major response rate. As of the May 31 cutoff, Iopofosine I 131 was found to have a major response rate of 56.4%...

Why Transcode Therapeutics (RNAZ) Stock Is Down 60%

Jul 23, 2024

Transcode Therapeutics Inc ( RNAZ ) shares are trading lower by 62% to $0.30 during Tuesday’s session after the company announced pricing of its public offering. The public offering of 10 million shares of its common stock will be at $0.30 per share, aiming to raise $3 million before deducting expenses. The offering is set to close on July 24,...